Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin + Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study)-Reference-Cited by-同舟云学术

Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin + Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study)

Published:2019-02 Issue:4 Volume:123 Page:611-617
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Huynh Thao^ORCID,Harty Brian J.,Claggett Brian,Fleg Jerome L.,McKinlay Sonja M.,Anand Inder S.^ORCID,Lewis Eldrin F.,Joseph Jacob,Desai Akshay S.,Sweitzer Nancy K.,EileenO'Meara ,Pitt Bertram,Pfeffer Marc A,Rouleau Jean-Lucien

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Trends in prevalence and outcome of heart failure with preserved ejection fraction;Owan;N Engl J Med,2006

2. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of reduction in mortality and morbidity (CHARM) programme;MacDonald;Eur Heart J,2008

3. Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE);Komajda;Circ Heart Failure,2011

4. What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE?;Campbell;J Am Coll Cardiol,2012

5. Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis;Martínez-Sellés;Eur J of Heart Failure,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review;International Journal of Molecular Sciences;2024-04-17

2. Risk of heart failure in patients with type 2 diabetes receiving insulin therapy: a meta-analysis of observational studies;Russian Journal of Cardiology;2023-04-15

3. Contemporary choice of glucose lowering agents in heart failure patients with type 2 diabetes;Expert Opinion on Pharmacotherapy;2022-11-20

4. Prognostic relevance of left atrial function and stiffness in heart failure with preserved ejection fraction patients with and without diabetes mellitus;Frontiers in Cardiovascular Medicine;2022-09-14

5. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation;European Journal of Preventive Cardiology;2022-08-25